BPC-157 vs TB-500
Updated 11 sources
Key differences
- 1BPC-157 is 15 amino acids and works locally on repair, blood vessels and the gut. TB-500 is a 7 amino acid fragment thought to act through cell migration across the body.
- 2BPC-157 is dosed daily and has an oral option. TB-500 is dosed once or twice a week by injection.
- 3No head-to-head study exists.
- 4TB-500 is thought to act body-wide through cell migration and is dosed once or twice a week. BPC-157 works locally on repair and the gut and is dosed daily.
Side by side
Facts from each record, in the same words as their own pages.
| BPC-157 | TB-500 | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
11 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study3
- He L et al. 2022, pharmacokinetics of BPC-157 in rats and dogs, Front PharmacolPubMed · checked Oct 23, 2026
- Ruff D et al. 2010, IV thymosin beta 4 in healthy volunteers, Ann N Y Acad SciPubMed · checked Oct 23, 2026
- TB-500 dosage chart (citing the 2021 recombinant thymosin beta-4 Phase 1)peptidedeck.com, via a competitor guide · checked Oct 23, 2026
Regulatory3
- FDA to remove 12 peptides from Category 2Frier Levitt · checked Oct 23, 2026
- An FDA committee just voted in favor of peptidesTIME, via a news report · checked Oct 23, 2026
- FDA panel votes to loosen restrictions for four peptidesPharmExec, via a news report · checked Oct 23, 2026
Competitor guide5
- BPC-157 protocolpeptidedosingprotocols.com · checked Oct 23, 2026
- BPC-157 overviewpeptides.org · checked Oct 23, 2026
- TB-500 protocolpeptidedosingprotocols.com · checked Oct 23, 2026
- TB-500 vs BPC-157peptides.org · checked Oct 23, 2026